Messenger RNA vaccines against SARS-CoV-2 #MMPMID33740443
Topol EJ
Cell 2021[Mar]; 184 (6): 1401 PMID33740443show ga
The first two vaccines proven to be effective for inhibiting COVID-19 illness were both mRNA, achieving 95% efficacy (and safety) among 74,000 participants (half receiving placebo) after intramuscular delivery of two shots, 3-4 weeks apart. To view this Bench to Bedside, open or download the PDF.